Carcinoma-induced vasculitis (Q96634): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
O surgimento de malignidade é relatado em até 5% dos pacientes com vasculite. Em pacientes com malignidade e vasculite, as meoplasias hematológicas são mais comuns. A vasculite também pode estar associada a tumores sólidos: câncer de rim, mama, ovário, pulmão, nasofaringe, estômago, intestino delgado, cólon e próstata. A vasculite leucocitoclástica é mais comum na vasculite induzida por malignidade, mas a vasculite de grandes vasos também pode surgir. A vasculite paraneoplásica deve ser sempre considerada, para realizar o diagnóstico precoce e o tratamento oportuno da malignidade subjacente. A maioria das vasculites paraneoplásicas não requer tratamento específico além daquele para a malignidade original.
description / endescription / en
 
Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.

Revision as of 12:39, 16 August 2026

Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.
Language Label Description Also known as
default for all languages
ID_1409323329
    English
    Carcinoma-induced vasculitis
    Emergence of malignancy is reported in up to 5% of patients with vasculitis. In patients with malignancy and vasculitis, hematologic malignancies are most common. Vasculitis can also be associated with solid tumours: kidney, breast, ovary, lung, nasopharynx, stomach, small bowel, colon, and prostate cancers. Leukocytoclastic vasculitis is most common in vasculitis induced by malignancy, but large-vessel vasculitis may also emerge. Paraneoplastic vasculitis should be kept in mind to accomplish early diagnosis and timely treatment of the underlying malignancy. Most paraneoplastic vasculitis requires no specific treatment other than that for the original malignancy.

      Statements